Biotype B of the whitefly, Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae), causes considerable losses to growers worldwide. Phytoseiid mites have been successfully used for the control of this pest in several countries. The Brazilian phytoseiid fauna is very diverse and potentially useful for this purpose. The aim of this study was to evaluate five Brazilian populations of phytoseiids as candidates for the control of the whitefly, a serious pest of different crops worldwide. Evaluated species were Amblydromalus limonicus (Garman & McGregor), Amblyseius herbicolus (Chant), Amblyseius largoensis (Muma), Amblyseius tamatavensis (Blommers), and Neoseiulus tunus (De Leon), which are found naturally in Brazil and elsewhere. The work was conducted at 28±1°C, 75±10% relative humidity, and a photoperiod of 12:12 (L:D) h. All evaluated phytoseiids preyed on eggs of B. tabaci, with the highest levels of predation recorded for Am. herbicolus and N. tunus, and highest level of oviposition recorded for Am. tamatavensis. The results show the Brazilian populations of those three species to be promising as control agents of B. tabaci. Aleuroglyphus ovatus (Troupeau) (Acari: Acaridae) was found to be a suitable prey for the mass production of those predators. Complementary studies are considered justified, given the positive results of this study.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.